Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:CE 25:6)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST003988 AN006569 Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active Cultured cells Human Cancer CNRS LC-MS
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky LC-MS
ST000114 AN000192 SIRM Analysis of human P493 cells under hypoxia in [U-13C] labeled Glucose medium B-cells Human Cancer University of Kentucky GC-MS/LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
  logo